Severe COVID-19 by SARS-CoV-2 Lineage B.1.1.7 in Vaccinated Solid-Organ Transplant Recipients: New Preventive Strategies Needed to Protect Immunocompromised Patients

被引:8
|
作者
Loconsole, Daniela [1 ]
Stea, Emma Diletta [1 ,2 ]
Sallustio, Anna [3 ]
Fonto, Giulia [2 ]
Pronzo, Virginia [2 ]
Simone, Simona [2 ]
Centrone, Francesca [1 ]
Accogli, Marisa [1 ]
Gesualdo, Loreto [2 ]
Chironna, Maria [1 ]
机构
[1] Univ Bari, Dept Biomed Sci & Human Oncol, Hyg Sect, I-70124 Bari, Italy
[2] Univ Bari, Dept Emergency & Organ Transplantat, Nephrol Dialysis & Transplantat Unit, I-70124 Bari, Italy
[3] Azienda Osped Univ, Hyg Unit, Consorziale Policlin Bari, I-70124 Bari, Italy
关键词
solid-organ transplant recipients; SARS-CoV-2; infection; B.1.1.7; lineage; COVID-19; vaccine; whole-genome sequencing;
D O I
10.3390/vaccines9080806
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Solid-organ transplant (SOT) recipients are at a high risk of severe COVID-19, and are priority for vaccination. Here, we describe three cases of severe COVID-19 caused by SARS-CoV-2 B.1.1.7 lineage in vaccinated SOT recipients. Methods: Three SOT patients were hospitalized in the Policlinico Hospital of Bari (southern Italy) and underwent nasopharyngeal swabs for molecular detection of SARS-CoV-2 genes and spike protein mutations by real-time PCR. One sample was subjected to whole-genome sequencing. Results: One patient was a heart transplant recipient and two were kidney transplant recipients. All were hospitalized with severe COVID-19 between March and May 2021. Two patients were fully vaccinated and one had received only one dose of the BNT162b2 mRNA vaccine. All the patients showed a high viral load at diagnosis, and molecular typing revealed the presence of B.1.1.7 lineage SARS-CoV-2. In all three cases, prolonged viral shedding was reported. Conclusions: The three cases pose concern about the role of the B.1.1.7 lineage in severe COVID-19 and about the efficacy of COVID-19 vaccination in immunocompromised patients. Protecting immunocompromised patients from COVID-19 is a challenge. SOT recipients show a suboptimal response to standard vaccination, and thus, an additive booster or a combined vaccination strategy with mRNA, protein/subunit, and vector-based vaccines may be necessary. This population should continue to practice strict COVID-19 precautions post-vaccination, until new strategies for protection are available.
引用
收藏
页数:8
相关论文
共 44 条
  • [1] SARS-CoV-2 B.1.1.7 reinfection after previous COVID-19 in two immunocompetent Italian patients
    Novazzi, Federica
    Baj, Andreina
    Genoni, Angelo
    Spezia, Pietro G.
    Colombo, Alberto
    Cassani, Gianluca
    Zago, Cristian
    Pasciuta, Renee
    Della Gasperina, Daniela
    Ageno, Walter
    Severgnini, Paolo
    Dentali, Francesco
    Focosi, Daniele
    Maggi, Fabrizio
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (09) : 5648 - 5649
  • [2] COVID-19 Recovery Patterns Across Alpha (B.1.1.7) and Delta (B.1.617.2) Variants of SARS-CoV-2
    Kumar, Nitya
    Quadri, Suha
    AlAwadhi, Abdulla Ismaeel
    AlQahtani, Manaf
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [3] SARS-CoV-2 anti-spike antibodies after a fourth dose of COVID-19 vaccine in adult solid-organ transplant recipients
    Perrier, Quentin
    Lupo, Julien
    Gerster, Theophile
    Augier, Caroline
    Falque, Loic
    Rostaing, Lionel
    Pelletier, Laurent
    Bedouch, Pierrick
    Blanc, Myriam
    Saint -Raymond, Christel
    Boignard, Aude
    Bonadona, Agnes
    Noble, Johan
    Epaulard, Olivier
    VACCINE, 2022, 40 (44) : 6404 - 6411
  • [4] Increased Residential Clustering of COVID-19 Cases Associated With SARS-CoV-2 Variant of Concern B.1.1.7
    Flannagan, Joe
    Twohig, Katherine A.
    Carter, Emma
    Chudasama, Dimple Y.
    Lamagni, Theresa
    Dabrera, Gavin
    EPIDEMIOLOGY, 2022, 33 (04) : 465 - 469
  • [5] Monitoring Emergence of the SARS-CoV-2 B.1.1.7 Variant through the Spanish National SARS-CoV-2 Wastewater Surveillance System (VATar COVID-19)
    Carcereny, Albert
    Martinez-Velazquez, Adan
    Bosch, Albert
    Allende, Ana
    Truchado, Pilar
    Cascales, Jenifer
    Romalde, Jesus L.
    Lois, Marta
    Polo, David
    Sanchez, Gloria
    Perez-Cataluna, Alba
    Diaz-Reolid, Azahara
    Anton, Andres
    Gregori, Josep
    Garcia-Cehic, Damir
    Quer, Josep
    Palau, Margarita
    Ruano, Cristina Gonzalez
    Pinto, Rosa M.
    Guix, Susana
    ENVIRONMENTAL SCIENCE & TECHNOLOGY, 2021, 55 (17) : 11756 - 11766
  • [6] SARS-CoV-2 B.1.1.7 UK Variant of Concern Lineage-Related Perceptions, COVID-19 Vaccine Acceptance and Travel Worry Among Healthcare Workers
    Temsah, Mohamad-Hani
    Barry, Mazin
    Aljamaan, Fadi
    Alhuzaimi, Abdullah N.
    Al-Eyadhy, Ayman
    Saddik, Basema
    Alsohime, Fahad
    Alhaboob, Ali
    Alhasan, Khalid
    Alaraj, Ali
    Halwani, Rabih
    Jamal, Amr
    Alamro, Nurah
    Temsah, Reem
    Esmaeil, Samia
    Alenezi, Shuliweeh
    Alzamil, Fahad
    Somily, Ali M.
    Al-Tawfiq, Jaffar A.
    FRONTIERS IN PUBLIC HEALTH, 2021, 9
  • [7] Comparison of the Performance of the PanBio COVID-19 Antigen Test in SARS-CoV-2 B.1.1.7 (Alpha) Variants versus non-B.1.1.7 Variants
    van Ogtrop, M. L.
    van de Laar, T. J. W.
    Eggink, D.
    Vanhommerig, J. W.
    van der Reijden, W. A.
    MICROBIOLOGY SPECTRUM, 2021, 9 (03):
  • [8] Antifungal prophylaxis with nebulized amphotericin-B in solid-organ transplant recipients with severe COVID-19: a retrospective observational study
    Rombauts, Alexander
    Bodro, Marta
    Daniel Gumucio, Victor
    Carbonell, Irene
    Fava, Alex
    Llado, Laura
    Gonzalez-Costello, Jose
    Oppenheimer, Federico
    Castel-Lavilla, Maria Angeles
    Len, Oscar
    Marquez-Algaba, Ester
    Nuvials-Casals, Xavier
    Martinez Gonzalez, Daniel
    Lacasa, Judith Sacanell
    Carratala, Jordi
    Sabe, Nuria
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 13
  • [9] Changing Features of COVID-19: Characteristics of Infections with the SARS-CoV-2 Delta (B.1.617.2) and Alpha (B.1.1.7) Variants in Southern Italy
    Loconsole, Daniela
    Centrone, Francesca
    Morcavallo, Caterina
    Campanella, Silvia
    Accogli, Marisa
    Sallustio, Anna
    Peccarisi, Davide
    Stufano, Angela
    Lovreglio, Piero
    Chironna, Maria
    VACCINES, 2021, 9 (11)
  • [10] Molecular Epidemiology of SARS-CoV-2 and Clinical Manifestations among Organ Transplant Recipients with COVID-19
    Alshukairi, Abeer N.
    Al-Qahtani, Ahmed A.
    Obeid, Dalia A.
    Dada, Ashraf
    Almaghrabi, Reem S.
    Al-Abdulkareem, Maha A.
    Alahideb, Basma M.
    Alsanea, Madain S.
    Alsuwairi, Feda A.
    Alhamlan, Fatimah S.
    VIRUSES-BASEL, 2024, 16 (01):